1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6CCEF3622A11D1ABF85258476002F6D20
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?Searchview&Query=(FIELD%20publishdate%20%3E=%201/11/2007)%20AND%20(FIELD%20Cats%20CONTAINS%20Sales)%20AND%20(the)%20and%20(field%20ItemCatalog=DB)&SearchWV=1&SearchFuzzy=1&SearchOrder=1&Start=1&Count=10
18
19Searchview&Query=(FIELD%20publishdate%20%3E=%201/11/2007)%20AND%20(FIELD%20Cats%20CONTAINS%20Sales)%20AND%20(the)%20and%20(field%20ItemCatalog=DB)&SearchWV=1&SearchFuzzy=1&SearchOrder=1&Start=1&Count=10
2018.205.109.82
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Search Results

Results 1 - 10 of 70 Total Hits, .

    |    

DB Image

Cariprazine: The Market Landscape for a Second-Generation Atypical AntipsychoticDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

STUDY OVERVIEW This short case study examines cariprazine, a second-generation atypical antipsychotic therapy developed by Forest Laboratories and Gedeon Richter... (ID 5302)
Companies Profiled: Forest Laboratories, Gedeon Richter Ltd.

$200.00

DB Image

Assessing Gamification Technologies and Approaches for the Pharma SectorDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

STUDY OVERVIEW The use of game elements to capture consumer's attention makes sense for business functions such as marketing or human resources... (ID 5294)
Companies Profiled: Eli Lilly, Genentech, Boehringer Ingelheim

$500.00

DB Image

Zyprexa: Portrait of a Successful Lifecycle for an Atypical AntipsychoticDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

STUDY OVERVIEW This 4-page case study examines Zyprexa, the third atypical antipsychotic therapy when it was approved in 1996 by the FDA... (ID 5303)
Companies Profiled: Eli Lilly

$200.00

DB Image

Vectibix Case Study: How Amgen Collaborated with the Colon Cancer Alliance to Ensure Market EducationDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

This case study reviews how Amgen interacted with a leading patient advocacy group to support Vectibix, a colorectal cancer treatment... (ID 5067)
Companies Profiled: Amgen

DB Image

Corporate's Role in Training & Supporting Effective Sales Reps CommunicationsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to sign-up for a complimentary tour of "Corporate's Role in Training & Supporting Effective Sales Reps Communications" STUD... (ID 4970)
Companies Profiled: Allergan, Purdue Pharma, Genentech, Eli Lilly, more ...

$1362.00

DB Image

Streamlining Pharmaceutical Sales Force Communication - Key FindingsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to sign-up for a complimentary tour of "Streamlining Pharmaceutical Sales Force Communication - Key Findings" STUDY OVERVIE... (ID 4968)
Companies Profiled: Sanofi-aventis, Purdue Pharma, Janssen, Pfizer, more ...

$1703.00

DB Image

Tecfidera Case Study: Using Safety as a Springboard for Blockbuster StatusDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Tecfidera Case Study: Using Safety as a Springboard for Blockbuster Status" STUDY OVE... (ID 5360)
Companies Profiled: Biogen, Sanofi, Novartis

DB Image

Competing in An Outcomes-Oriented Healthcare WorldDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

STUDY OVERVIEW As payers flex increasing muscle in the pharmaceutical marketplace, cost and effectiveness have become key components of a product's success... (ID 5332)

FREE

DB Image

Disease State Awareness Programs for Orphan DrugsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics.

STUDY OVERVIEW Pharmaceutical companies use disease state awareness programs to raise awareness among consumers and healthcare practitioners about a... (ID 5301)
Companies Profiled: AstraZeneca, Alexion Pharmaceuticals, Bristol-Myers Squibb, Vertex Pharmaceuticals

$550.00

DB Image

Nexavar Case Study: Using Publications and Presentations to Inform Practitioners and PatientsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Non-members: Click here to review a complimentary excerpt from "Nexavar Case Study: Using Publications and Presentations to Inform Practitioners and ... (ID 5057)
Companies Profiled: Bayer, Onyx Pharmaceuticals